ROMEI, CRISTINA Statistiche
ROMEI, CRISTINA
DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE
, Descrizione della prima mutazione omozigote germinale di RET (Ala883->Thr) che non determina l'insorgenza del carcinoma midollare della tiroide in condizioni di eterozigosi
2003-01-01 Cosci, Barbara; Romei, Cristina; Agate, Laura; Piampiani, P; Vivaldi, A; Ciampi, R; Nikiforov, Y; Pinchera, Aldo; Elisei, Rossella
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion.
2019-01-01 Giani, Carlotta; Romei, Cristina; Ciampi, Raffaele; Valerio, Laura; Tacito, Alessia; Ramone, Teresa; Materazzi, Gabriele; Torregrossa, Liborio; Ugolini, Clara; Franchi, Alessandro; Basolo, Fulvio; Agate, Laura; Elisei, Rossella
A comprehensive meta-analysis of case-control association studies to evaluate polymorphisms associated with the risk of differentiated thyroid carcinoma
2016-01-01 Figlioli, Gisella; Elisei, Rossella; Romei, Cristina; Melaiu, Ombretta; Cipollini, Monica; Bambi, Franco; Chen, Bowang; Köhler, Aleksandra; Cristaudo, Alfonso; Hemminki, Kari; Gemignani, Federica; Försti, Asta; Landi, Stefano
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma
2016-01-01 Romei, Cristina; Ciampi, Raffaele; Elisei, Rossella
A narrative review of genetic alterations in primary thyroid epithelial cancer
2021-01-01 Romei, C.; Elisei, R.
A new germline RET mutation apparently devoid of transforming activity serendipitously discovered in a patient with atrophic autoimmune thyroiditis and primary ovarian failure
2004-01-01 Orgiana, G; Pinna, G; Camedda, A; DE FALCO, V; Santoro, M; Melillo, Rm; Elisei, Rossella; Romei, Cristina; Lai, S; Carcassi, C; Mariotti, Stefano
A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion
2020-01-01 Giani, C.; Ramone, T.; Romei, C.; Ciampi, R.; Tacito, A.; Valerio, L.; Agate, L.; Ugolini, C.; Marino, M.; Basolo, F.; Franchi, A.; Borsari, S.; Michelucci, A.; Selli, C.; Materazzi, G.; Cetani, F.; Elisei, R.
A novel fusion RET/PTC3 involving NCOA4 and RET genes in a pediatric case of Papillary Thyroid Carcinoma
2015-01-01 Ciampi, Raffaele; Romei, Cristina; Tacito, Alessia; Casella, Francesca; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Matrone, Antonio; Vitti, Paolo; Elisei, Rossella
After 20 Years, RET genetic screening still identifies new germline and somatic mutations
2013-01-01 Tacito, A; Romei, C; Vivaldi, A; Ciampi, R; Matrone, A; Bottici, V; Cappagli, V; Elisei, R
AFTER 20 YEARS, RET GENETIC SCREENING STILL INDENTIFIES NEW GERMILINE AND SOMATIC MUTATIONS
2013-01-01 Tacito, Alessia; Romei, Cristina; Vivaldi, Agnese; Ciampi, Raffaele; Matrone, Antonio; Bottici, Valeria; Cappagli, Virginia; Elisei, Rossella
ALL-TRANS RETINOIC ACID TREATMENT INHIBITS THE GROWTH OF RARb mRNA EXPRESSING THYROID CANCER CELL LINES BUT DOES NOT RE-INDUCE THE EXPRESSION OF THYROID SPECIFIC GENES
2005-01-01 Elisei, Rossella; Vivaldi, A; Agate, Laura; Ciampi, R; Molinaro, Eleonora; Piampiani, P; Romei, Cristina; Faviana, Pinuccia; Basolo, Fulvio; Miccoli, Paolo; Capodanno, A; Collecchi, P; Pacini, F; Pinchera, Aldo
Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1
2003-01-01 Maio, M; Coral, S; Sigalotti, S; Elisei, Rossella; Romei, Cristina; Rossi, G; Cortini, E; Colizzi, F; Fenzi, G; Altomonte, M; Pinchera, Aldo; Vitale, M.
Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma
2018-01-01 Condello, Vincenzo; Macerola, Elisabetta; Ugolini, Clara; De Napoli, Luigi; Romei, Cristina; Materazzi, Gabriele; Elisei, Rossella; Basolo, Fulvio
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
2017-01-01 Molinaro, Eleonora; Romei, Cristina; Biagini, Agnese; Sabini, Elena; Agate, Laura; Mazzeo, Salvatore; Materazzi, Gabriele; SELLARI FRANCESCHINI, Stefano; Ribechini, Alessandro; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma
2016-01-01 Pellè, Lucia; Cipollini, Monica; Tremmel, Roman; Romei, Cristina; Figlioli, Gisella; Gemignani, Federica; Melaiu, Ombretta; DE SANTI, Chiara; Barone, Elisa; Elisei, Rossella; Seiser, Eric; Innocenti, Federico; Zanger, Ulrich M.; Landi, Stefano
BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas
2004-01-01 Puxeddu, E; Moretti, S; Elisei, Rossella; Romei, Cristina; Pascucci, R; Martinelli, M; Marino, C; Avenia, N; Rossi, Ed; Fadda, G; Cavaliere, A; Ribacchi, R; Falorni, A; Pontecorvi, A; Pacini, F; Pinchera, A; Santeusanio, F.
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study
2008-01-01 Elisei, Rossella; Ugolini, C; Viola, David; Lupi, C; Biagini, Agnese; Giannini, Riccardo; Romei, Cristina; Miccoli, Paolo; Pinchera, Aldo; Basolo, Fulvio
BRAFV600E mutation is an indipendent bad prognostic factor for the out come of patients with papillary thyroid carcinoma: a 15-year median follow-up study.
2007-01-01 Viola, David; Ugolini, Clara; Lupi, Cristiana; Biagini, Agnese; Giannini, Riccardo; Romei, Cristina; Miccoli, Paolo; Pinchera, Aldo; Basolo, Fulvio; Elisei, Rossella
Ca19.9 positivity and doubling time are prognostic factors of mortality in patients with advanced medullary thyroid cancer with no evidence of structural disease progression according to RECIST
2021-01-01 Lorusso, Loredana; Romei, Cristina; Piaggi, Paolo; Fustini, Chiara; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Pellegrini, Giovanni; Elisei, Rossella
Calcitonin estimation in patients with nodular goiter and its significance for early detection of MTC: european comments to the guidelines of the American Thyroid Association
2013-01-01 Elisei, Rossella; Romei, Cristina
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
, Descrizione della prima mutazione omozigote germinale di RET (Ala883->Thr) che non determina l'insorgenza del carcinoma midollare della tiroide in condizioni di eterozigosi | 1-gen-2003 | Cosci, Barbara; Romei, Cristina; Agate, Laura; Piampiani, P; Vivaldi, A; Ciampi, R; Nikiforov, Y; Pinchera, Aldo; Elisei, Rossella | |
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. | 1-gen-2019 | Giani, Carlotta; Romei, Cristina; Ciampi, Raffaele; Valerio, Laura; Tacito, Alessia; Ramone, Teresa; Materazzi, Gabriele; Torregrossa, Liborio; Ugolini, Clara; Franchi, Alessandro; Basolo, Fulvio; Agate, Laura; Elisei, Rossella | |
A comprehensive meta-analysis of case-control association studies to evaluate polymorphisms associated with the risk of differentiated thyroid carcinoma | 1-gen-2016 | Figlioli, Gisella; Elisei, Rossella; Romei, Cristina; Melaiu, Ombretta; Cipollini, Monica; Bambi, Franco; Chen, Bowang; Köhler, Aleksandra; Cristaudo, Alfonso; Hemminki, Kari; Gemignani, Federica; Försti, Asta; Landi, Stefano | |
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma | 1-gen-2016 | Romei, Cristina; Ciampi, Raffaele; Elisei, Rossella | |
A narrative review of genetic alterations in primary thyroid epithelial cancer | 1-gen-2021 | Romei, C.; Elisei, R. | |
A new germline RET mutation apparently devoid of transforming activity serendipitously discovered in a patient with atrophic autoimmune thyroiditis and primary ovarian failure | 1-gen-2004 | Orgiana, G; Pinna, G; Camedda, A; DE FALCO, V; Santoro, M; Melillo, Rm; Elisei, Rossella; Romei, Cristina; Lai, S; Carcassi, C; Mariotti, Stefano | |
A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion | 1-gen-2020 | Giani, C.; Ramone, T.; Romei, C.; Ciampi, R.; Tacito, A.; Valerio, L.; Agate, L.; Ugolini, C.; Marino, M.; Basolo, F.; Franchi, A.; Borsari, S.; Michelucci, A.; Selli, C.; Materazzi, G.; Cetani, F.; Elisei, R. | |
A novel fusion RET/PTC3 involving NCOA4 and RET genes in a pediatric case of Papillary Thyroid Carcinoma | 1-gen-2015 | Ciampi, Raffaele; Romei, Cristina; Tacito, Alessia; Casella, Francesca; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Matrone, Antonio; Vitti, Paolo; Elisei, Rossella | |
After 20 Years, RET genetic screening still identifies new germline and somatic mutations | 1-gen-2013 | Tacito, A; Romei, C; Vivaldi, A; Ciampi, R; Matrone, A; Bottici, V; Cappagli, V; Elisei, R | |
AFTER 20 YEARS, RET GENETIC SCREENING STILL INDENTIFIES NEW GERMILINE AND SOMATIC MUTATIONS | 1-gen-2013 | Tacito, Alessia; Romei, Cristina; Vivaldi, Agnese; Ciampi, Raffaele; Matrone, Antonio; Bottici, Valeria; Cappagli, Virginia; Elisei, Rossella | |
ALL-TRANS RETINOIC ACID TREATMENT INHIBITS THE GROWTH OF RARb mRNA EXPRESSING THYROID CANCER CELL LINES BUT DOES NOT RE-INDUCE THE EXPRESSION OF THYROID SPECIFIC GENES | 1-gen-2005 | Elisei, Rossella; Vivaldi, A; Agate, Laura; Ciampi, R; Molinaro, Eleonora; Piampiani, P; Romei, Cristina; Faviana, Pinuccia; Basolo, Fulvio; Miccoli, Paolo; Capodanno, A; Collecchi, P; Pacini, F; Pinchera, Aldo | |
Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1 | 1-gen-2003 | Maio, M; Coral, S; Sigalotti, S; Elisei, Rossella; Romei, Cristina; Rossi, G; Cortini, E; Colizzi, F; Fenzi, G; Altomonte, M; Pinchera, Aldo; Vitale, M. | |
Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma | 1-gen-2018 | Condello, Vincenzo; Macerola, Elisabetta; Ugolini, Clara; De Napoli, Luigi; Romei, Cristina; Materazzi, Gabriele; Elisei, Rossella; Basolo, Fulvio | |
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies | 1-gen-2017 | Molinaro, Eleonora; Romei, Cristina; Biagini, Agnese; Sabini, Elena; Agate, Laura; Mazzeo, Salvatore; Materazzi, Gabriele; SELLARI FRANCESCHINI, Stefano; Ribechini, Alessandro; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella | |
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma | 1-gen-2016 | Pellè, Lucia; Cipollini, Monica; Tremmel, Roman; Romei, Cristina; Figlioli, Gisella; Gemignani, Federica; Melaiu, Ombretta; DE SANTI, Chiara; Barone, Elisa; Elisei, Rossella; Seiser, Eric; Innocenti, Federico; Zanger, Ulrich M.; Landi, Stefano | |
BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas | 1-gen-2004 | Puxeddu, E; Moretti, S; Elisei, Rossella; Romei, Cristina; Pascucci, R; Martinelli, M; Marino, C; Avenia, N; Rossi, Ed; Fadda, G; Cavaliere, A; Ribacchi, R; Falorni, A; Pontecorvi, A; Pacini, F; Pinchera, A; Santeusanio, F. | |
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study | 1-gen-2008 | Elisei, Rossella; Ugolini, C; Viola, David; Lupi, C; Biagini, Agnese; Giannini, Riccardo; Romei, Cristina; Miccoli, Paolo; Pinchera, Aldo; Basolo, Fulvio | |
BRAFV600E mutation is an indipendent bad prognostic factor for the out come of patients with papillary thyroid carcinoma: a 15-year median follow-up study. | 1-gen-2007 | Viola, David; Ugolini, Clara; Lupi, Cristiana; Biagini, Agnese; Giannini, Riccardo; Romei, Cristina; Miccoli, Paolo; Pinchera, Aldo; Basolo, Fulvio; Elisei, Rossella | |
Ca19.9 positivity and doubling time are prognostic factors of mortality in patients with advanced medullary thyroid cancer with no evidence of structural disease progression according to RECIST | 1-gen-2021 | Lorusso, Loredana; Romei, Cristina; Piaggi, Paolo; Fustini, Chiara; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Pellegrini, Giovanni; Elisei, Rossella | |
Calcitonin estimation in patients with nodular goiter and its significance for early detection of MTC: european comments to the guidelines of the American Thyroid Association | 1-gen-2013 | Elisei, Rossella; Romei, Cristina |